Lymphocyte-Mediated Immune Regulation in Health and Disease: The Treg and γδ T Cell Co-Conspiracy

Por Payne, Kyle K.
Publicado no Immunol Invest (2016)

Cancer immunotherapy: Re-programming cells of the innate and adaptive immune systems

Por Manjili, Masoud H., Payne, Kyle K.
Publicado em 2012

Estrogens drive myeloid-derived suppressor cell accumulation

Por Conejo-Garcia, Jose R., Payne, Kyle K., Svoronos, Nikolaos
Publicado no Oncoscience (2017)

HLA-DR expression on myeloid cells is a potential prognostic factor in patients with high-risk neuroblastoma

Por Gowda, Madhu, Payne, Kyle K, Godder, Kamar, Manjili, Masoud H
Publicado em 2013

IFN-γ Rα Is a Key Determinant of CD8+ T Cell-Mediated Tumor Elimination or Tumor Escape and Relapse in FVB Mouse

Por Kmieciak, Maciej, Payne, Kyle K., Wang, Xiang-Yang, Manjili, Masoud H.
Publicado em 2013

Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk

Por Payne, Kyle K., Toor, Amir A., Wang, Xiang-Yang, Manjili, Masoud H.
Publicado em 2012

DNA methyltransferase inhibition increases efficacy of adoptive cellular immunotherapy of murine breast cancer

Por Terracina, Krista P., Graham, Laura J., Payne, Kyle K., Manjili, Masoud H., Baek, Annabel, Damle, Sheela R., Bear, Harry D.
Publicado no Cancer Immunol Immunother (2016)

Activated NK T cells and NK cells render T cells resistant to MDSC and result in an effective adoptive cellular therapy against breast cancer in the FVBN202 transgenic mouse

Por Kmieciak, Maciej, Basu, Debasmita, Payne, Kyle K, Toor, Amir, Yacoub, Adly, Wang, Xiang-Yang, Smith, Lisa, Bear, Harry D, Manjili, Masoud H
Publicado em 2011

Coordinated Upregulation of Mitochondrial Biogenesis and Autophagy in Breast Cancer Cells: The Role of Dynamin Related Protein-1 and Implication for Breast Cancer Treatment

Por Zou, Peng, Liu, Longhua, Zheng, Louise D., Payne, Kyle K., Manjili, Masoud H., Idowu, Michael O., Zhang, Jinfeng, Schmelz, Eva M., Cheng, Zhiyong
Publicado no Oxid Med Cell Longev (2016)

Peripheral blood mononuclear cells of breast cancer patients can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells

Por Payne, Kyle K, Zoon, Christine K, Wan, Wen, Marlar, Khin, Keim, Rebecca C, Kenari, Mehrab Nasiri, Kazim, Latif, Bear, Harry D, Manjili, Masoud H
Publicado em 2013

Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells

Por Payne, Kyle K, Zoon, Christine K, Wan, Wen, Marlar, Khin, Keim, Rebecca C, Kenari, Mehrab Nasiri, Kazim, A Latif, Bear, Harry D, Manjili, Masoud H
Publicado no Breast Cancer Res Treat (2013)

Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cells

Por Payne, Kyle K., Keim, Rebecca C., Graham, Laura, Idowu, Michael O., Wan, Wen, Wang, Xiang-Yang, Toor, Amir A., Bear, Harry D., Manjili, Masoud H.
Publicado no J Leukoc Biol (2016)

Tumor escape and progression of HER-2/neu negative breast cancer under immune pressure

Por Kmieciak, Maciej, Payne, Kyle K, Idowu, Michael O, Grimes, Margaret M, Graham, Laura, Ascierto, Maria-Libera, Wang, Ena, Wang, Xiang-Yang, Bear, Harry D, Manjili, Masoud H
Publicado em 2011

TRAMETINIB DRIVES T CELL-DEPENDENT CONTROL OF K-RAS-MUTATED TUMORS BY INHIBITING PATHOLOGICAL MYELOPOIESIS

Por Allegrezza, Michael J., Rutkowski, Melanie R., Stephen, Tom L., Svoronos, Nikolaos, Perales-Puchalt, Alfredo, Nguyen, Jenny M., Payne, Kyle K., Singhal, Sunil, Eruslanov, Evgeniy B., Tchou, Julia, Conejo-Garcia, Jose R.
Publicado no Cancer Res (2016)

Epigenetic induction of adaptive immune response in multiple myeloma: sequential azacitidine and lenalidomide generate cancer testis antigen-specific cellular immunity

Por Toor, Amir A., Payne, Kyle K., Chung, Harold M., Sabo, Roy T., Hazlett, Allison F., Kmieciak, Maciej, Sanford, Kimberly, Williams, David C., Clark, William B., Roberts, Catherine H., McCarty, John M., Manjili, Masoud H.
Publicado no Br J Haematol (2012)

Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients

Por Ascierto, Maria Libera, Idowu, Michael O, Zhao, Yingdong, Khalak, Hanif, Payne, Kyle K, Wang, Xiang-Yang, Dumur, Catherine I, Bedognetti, Davide, Tomei, Sara, Ascierto, Paolo A, Shanker, Anil, Bear, Harry D, Wang, Ena, Marincola, Francesco M, De Maria, Andrea
Publicado em 2013

Tumor Cell-Independent Estrogen Signaling Drives Disease Progression Through Mobilization of Myeloid-Derived Suppressor Cells

Por Svoronos, Nikolaos, Perales-Puchalt, Alfredo, Allegrezza, Michael J., Rutkowski, Melanie R., Payne, Kyle K., Tesone, Amelia J., Nguyen, Jenny M., Curiel, Tyler J., Cadungog, Mark G., Singhal, Sunil, Eruslanov, Evgeniy B., Zhang, Paul, Tchou, Julia, Zhang, Rugang, Conejo-Garcia, Jose R.
Publicado no Cancer Discov (2016)

SATB1 OVEREXPRESSION DRIVES TUMOR-PROMOTING ACTIVITIES IN CANCER-ASSOCIATED DENDRITIC CELLS

Por Tesone, Amelia J., Rutkowski, Melanie R., Brencicova, Eva, Svoronos, Nikolaos, Perales-Puchalt, Alfredo, Stephen, Tom L., Allegrezza, Michael J., Payne, Kyle K., Nguyen, Jenny M., Wickramasinghe, Jayamanna, Tchou, Julia, Borowsky, Mark E., Rabinovich, Gabriel A., Kossenkov, Andrew V., Conejo-Garcia, Jose R.
Publicado no Cell Rep (2016)

SATB1 Expression Governs Epigenetic Repression of PD-1 in Tumor-Reactive T Cells

Por Stephen, Tom L., Payne, Kyle K., Chaurio, Ricardo A., Allegrezza, Michael J., Zhu, Hengrui, Perez-Sanz, Jairo, Perales-Puchalt, Alfredo, Nguyen, Jenny M., Vara-Ailor, Ana E., Eruslanov, Evgeniy B., Borowsky, Mark E., Zhang, Rugang, Laufer, Terri M., Conejo-Garcia, Jose R.
Publicado no Immunity (2017)

FOLLICLE-STIMULATING HORMONE RECEPTOR IS EXPRESSED BY MOST OVARIAN CANCER SUBTYPES AND IS A SAFE AND EFFECTIVE IMMUNOTHERAPEUTIC TARGET

Por Perales-Puchalt, Alfredo, Svoronos, Nikolaos, Rutkowski, Melanie R, Allegrezza, Michael J, Tesone, Amelia J, Payne, Kyle K, Wickramasinghe, Jayamanna, Nguyen, Jenny M, O'Brien, Shane W, Gumireddy, Kiranmai, Huang, Qihong, Cadungog, Mark G., Connolly, Denise C, Tchou, Julia, Curiel, Tyler J, Conejo-Garcia, Jose R.
Publicado no Clin Cancer Res (2016)